Meet the team

Dr Arthur Morris

BSc (Hons I) MD D(ABMM) FRCPA FFSc(RCPA) CMInstD

Board Member

Arthur Morris obtained his undergraduate science and medical
degrees from the University of Otago and his MD from the
University of Auckland. He trained in clinical microbiology in
Auckland and obtained his RCPA fellowship in 1989.

Dr Morris recently completed his term as chair of the RCPAQAP
Microbiology Programme, is a member of the RCPA Overseas
Trained Specialist interview panel and a College examiner in
clinical microbiology.

He has governance experience in listed and unlisted companies
and not-for-profit trusts and charities. He is a charter member of
the New Zealand Institute of Directors.

Prof Dominic Mallon

Clinical Professor, MB BS FRACP FRCPA FFSc(RCPA) GAICD

Board Member

Professor Dominic Mallon is the Head of Clinical Service, Immunology at Fiona Stanley Hospital and the immediate past Chief Pathologist of PathWest.

Dominic is a clinician who practises a broad range of immunopathology, allergy and clinical immunology looking after both children and adults with immunological and allergic disorders. Dominic also collaborates in clinical research projects into the mechanisms of tolerance induction in immunotherapy for allergic diseases; and impairment of tolerance mechanisms in autoimmunity.

Dominic is a former President of the Australasian Society of Clinical Immunology and Allergy (ASCIA) and of Public Pathology Australia.

Prof Fiona Maclean

MBBS (Hons I), BAppSc, FRCPA, GAICD

Dr Janice Fletcher

MBBS (Hons I) MD BSc FRACP FRCPA, GAICD

Chair

Janice Fletcher is a retired paediatrician, clinical geneticist and genetic pathologist. After a career in metabolic diseases and newborn screening, she focused on bringing cost-effective diagnostic next-generation sequencing into routine clinical use in both South Australia and NSW.  Her work spans professional education, achieving quality outcomes in newborn screening and genetic diseases, and improving the interface between the laboratory and the clinician.

She is a member of the Medical Services Advisory Committee and the Lifesaving Drugs Program Advisory Panel and has recently retired from the TGA’s Advisory Committee on Medicines.

Mark Meehan

BE, MBA, GAICD

Board Member

Mark is a company director, consultant and mentor with a background in international business, technology and strategy execution.  Mark executive held roles with major global businesses such as AXA, Cisco, Avaya, General Cable Plc and Equant and operated in Australia, UK, Europe, India and Singapore.

Earlier Mark was an Officer in the Australian Army and is a graduate of the Royal Military College, Duntroon and the UK Royal Military College of Science, Shrivenham.

Dr Rebecca Adams

B.Mus, MBBS (Hons I), FRCPA, AFRACMA, GAICD

Board Member

Dr Rebecca Adams graduated in medicine with First Class Honours from The University of Queensland in 2004, receiving the University Medal for Medicine, and several other academic prizes including the Lilian Cooper Prize for highest overall achievement over four years. She was awarded Fellowship of the Royal College of Pathologists of Australasia (RCPA) in 2014, and in 2019 also became a graduate of the Australian Institute of Company Directors.

Rebecca is a haematologist at Sullivan Nicolaides Pathology whose practice encompasses a broad range of diagnostic haematology. She also maintains a strong interest in education and training, and is the Training Network Coordinator for Haematology Advanced Training in Queensland as well as the Associate Chief Examiner in Haematology for the RCPA.

She serves on a number of committees, including the RCPA Queensland State Committee, the RCPA Haematology Advisory Committee, and the RPCA Overseas Trained Specialist interview panel, and is currently Chair of the Pathology Update Haematology Scientific Program Committee and a senior lecturer at The University of Queensland.

Richard Fogl

BCom, LLB, GAICD

Board Member

Richard Fogl is a solicitor and was the principal legal adviser to RCPAQAP and The Royal College of Pathologists of Australasia for many years prior to his retirement from full time legal practice in 2020. Richard was admitted as a solicitor in NSW in 1984 and has practiced as a lawyer in Australia, Hong Kong and England. He has extensive experience in advising company boards on a wide range of commercial and governance issues.

Richard was an elected board member for 5 years and also led the Australian life sciences and healthcare practice for 7 years at a major international law firm. He has advised global pharmaceutical and medical device companies as well as many health services companies during his legal career. Richard has also been the pro bono lawyer for indigenous health providers.

Dr Samuel Vasikaran

MBBS MSc MD FRCPA FFSc(RCPA)

Prof Sandra O'Toole

MBBS (Hons I), BMedSc (Hons I), PhD, FRCPA, FFSc (RCPA)

Professor Beena Kumar

Anatomical Pathology Chair

Beena Kumar is the Program Director of Pathology Monash Health, Victoria, Australia. She has held medical leadership roles within the Department of Pathology, the Anatomical Pathology and the Diagnostic Genomics Unit.

She is a specialist anatomical pathologist with more than twenty years of specialist experience. She has keen interest in breast, haematolymphoid and neuropathology pathology and is the designated pathologist for Monash Breast Screen at Monash Health.

Beena holds an academic position within the School of Clinical Sciences, affiliated with Monash University. She is involved in medical research and has worked as a post-doctoral fellow at the Walter and Eliza Hall Institute of Medical Research and the University of Melbourne.

Prof William Rawlinson

Biosecurity Chair

Qualifications: AM FAHMS BSc(Med) MBBS PhD (Cantab) GCM FRACP FRCPA FASM FFSc

Director of Serology and Virology Division (SAViD), Director Organ and Tissue Donor screening laboratory, Director NSW State Reference Laboratory for HIV, Chair Biosecurity Quality Assurance Program (QAP) RCPAQAP, Deputy Chair Serology Quality Assurance Program (QAP) RCPAQAP

William Rawlinson is a clinician scientist recognised internationally for translational research into human CMV in pregnancy and other immune compromised clinical states. He established, and oversees, serology and virology clinical research programs, statewide transplant donor screening, and national quality programs for serology and biosecurity. The laboratory he directs studies pathogenesis of congenital CMV infection, clinical application of research findings to pregnant women and neonates, and novel antivirals. He is conjoint professor at UNSW with over 400 publications in basic research, diagnostic and clinical virology.

Dr Chris Farrell

Chemical Pathology Chair

Qualifications: BSc (Med), MBBS, FAACB, FRACP

Chris is the Clinical Director at Liverpool in Sydney. He trained in chemical pathology at Royal North Shore Hospital and Laverty Pathology. After obtaining Fellowship in 2012, he continued with Laverty Pathology, eventually becoming Director of Clinical Chemistry and Laverty Pathology.

Chris has a keen interest in the education and training of pathologists and scientists. He was previously the NSW/ACT education representative for the Australasian Association for Clinical Biochemistry and Laboratory Medicine (AACB) and is currently on the AACB Board of Examiners. In his research, he is currently interested in the use of laboratory data to answer clinical questions, streamline laboratory workflows and improve analytical quality.

Dr Shaun Donovan

Cytopathology Chair

Dr. Shaun Donovan commenced in the role of Chief Executive Officer of Diagnostic Services in March 2017. He is a graduate of the University of Tasmania Medical School and underwent his Anatomical Pathology training at the Royal Hobart Hospital and St. Vincent’s Hospital in Melbourne.

Having a long association with the University of Tasmania medical undergraduate course, Dr Donovan has provided lectures and tutorials in gastrointestinal, breast, liver and male genitourinary pathology.
In addition to his duties as CEO he is the State Supervising Anatomical Pathologist for Diagnostic Services, maintaining a clinical workload reporting the full spectrum of histopathology and cytopathology and providing many pathology review meetings for referring doctors in addition to his administrative role.

Dr John Giannoutsos

Haematology Chair

Dr Giannoutsos obtained his MBChB in South Africa at the University of Cape Town/Groote Schuur Hospital, following which he completed a B Mus at the University of Witwatersrand in Johannesburg. Subsequently, he trained in laboratory haematology followed by clinical haematology training at Groote Schuur Hospital and then worked as a haematologist in the United Kingdom. After a period of registrar training in haematology in Australia, he obtained the FRCPA in haematology in 2007. In 2009 he was appointed staff specialist in haematology at Nepean Hospital, where he is currently employed as part of the New South Wales Health Pathology service.

Topics on which Dr Giannoutsos has published in peer-reviewed journals include bone marrow pathology, while abstracts, posters and presentations include morphology, various clinical case reports and quality assurance. Dr Giannoutsos is a member of the Haematology Clinical Stream for NSW Health Pathology whose functions include the roll-out of digital morphology in NSW and is involved with a web-based morphology training project. He assumed the role of chair for the Haematology Advisory Committee of the RCPAQAP at the end of 2017.

A/Prof Frederick J Lee

Immunology Chair

Qualifications: BSc, MBBS(Hons), PhD, FRACP, FRCPA

Frederick is a Senior Staff Specialist at the Royal Prince Alfred Hospital, Sydney, the current Clinical Stream Directorfor Immunology at New South Wales Health Pathology and a Clinical Associate Professor in the Faculty of Medicine and Health, University of Sydney. 

Frederick holds a doctorate from the University of New South Wales for studies in the field of antiretroviral therapy and has been involved with the RCPAQAP since 2014, when he co-ordinated the transition of the Immunology Program to its present headquarters.

At his diagnostic site, Frederick oversees autoimmune, immunochemical and flow cytometric tests, and he has a particular interest in HIV diagnostics. He maintains an active role in vocational training as the current Chief Examiner (Immunopathology) of the Royal College of Pathologists of Australasia (RCPA) and a member of the Committee for Joint College Training of the Royal Australasian College of Physicians (RACP) for Immunology/Allergy. 

Professor David Roxby

KIMMS Chair

Qualifications: B App Sc, M App Sc, ARCPA, FFScRCPA, PhD

David’s areas of interest include the interface between the laboratory and clinical practice, improvement in transfusion practices, and he has a long-standing research track record in Transfusion Medicine.

 David is a Professor in the College of Medicine and Public Health at Flinders University, with extensive experience in clinical and laboratory Transfusion Medicine. Previously, he was Head of the SA Pathology Transfusion Service for many years. He has received numerous awards and research grants and co-authored more than 50 peer-reviewed scientific papers.

 His knowledge and expertise in patient blood management have been recognized as a member of the National Blood Authority Patient Blood Management Advisory Committee and other national committees.

Dr Juliet Elvy

Microbiology Chair

Qualifications: BMedSci, BMBS, MRCP, FRCPath, FRCPA

Juliet is a Consultant Clinical Microbiologist based at both Wellington Southern Community Laboratories and Medlab Nelson Marlborough, New Zealand. 

She completed her training in the southwest UK in 2011 and moved to New Zealand in 2012. In her role as a clinical microbiologist, she has responsibility for a number of clinical microbiology laboratories across the South Island of New Zealand as well as the Wellington region. She is a fellow of both the Royal College of Pathologists of Australasia and the Royal College of Pathologists (UK). Her particular interests include antimicrobial resistance, antimicrobial susceptibility testing, antimicrobial stewardship and Choosing Wisely. She is passionate about quality and has been chair of the RCPAQAP Microbiology Advisory Committee since 2018. She is a key member of the New Zealand National Antimicrobial Testing Committee and the New Zealand Microbiology Network. 

Dr Eric Lee

Molecular Genetics Chair

Qualifications: MBBS, FRCPA (Genetics)

Eric is the medical laboratory director for Virtus Genetics, a private pathology provider of reproductive genetic testing. He is a member of the RCPA Genetics Advisory Committee and deputy chief examiner for the RCPA Medical Genomics examinations. He has been chair of the RCPAQAP Molecular Genetics Advisory Committee since 2022. Eric is experienced in the development and interpretation of a wide range of molecular and cytogenetic tests.

Dr Meryta May

Serology Chair

Dr Meryta May graduated from The University of Queensland in 1995 and is a paediatric infectious diseases physician and microbiologist. She joined Sullivan Nicolaides Pathology in 2004 after completing her paediatric infectious diseases training in Sydney at the Children’s Hospital at Westmead, and Liverpool Hospital. Prior to this she worked in rural Queensland and at both of Queensland’s tertiary paediatric hospitals.

She has a particular interest in infectious disease diagnostics and has published on a wide range of paediatric infectious disease topics. As a member of ANZPID (Australia and New Zealand Paediatric Infectious Diseases) special interest group she has contributed to national guidelines for fungal infections in the immunocompromised and C. difficile infections in children.

Dr May is a member of ASID and the National Certification Committee for the eradication of polio. She is an editor for the Journal of Paediatrics and Child Health and consults clinically at Queensland Children’s Hospital, Wesley Hospital and St Andrew’s Hospital.

Dr Michael Spies

Synovial Fluid Chair

Dr Michael Spies is a Rheumatology Staff Specialist at the Department of Rheumatology at Royal Prince Alfred Hospital, where he provides care for patients in the Gout and Crystal Arthritis Clinic. He also has a keen interest in education and training and is the current Network Director of Physician Training for the Royal Prince Alfred Hospital Basic Physician Training Network. Dr Spies is a Clinical Senior Lecturer at the University of Sydney. He is the current Chair of the Synovial Fluid RCPAQAP, having succeeded A/Prof Neil McGill. The program provides quality assurance and teaching of synovial fluid examination for crystals to laboratories throughout Australia and further afield. Distribution of synovial fluid samples, yearly on-line teaching and in-person workshops are included in the program. The synovial fluid crystal teaching activities are assisted by world-class photographic and computer equipment in the Department of Rheumatology at Royal Prince Alfred Hospital.